旋转动脉切除术设施标准修订对PCI后结果的影响:一个准实验差异差异研究
Tadao Aikawa1, Yuichiro Mori2, Toshiki Kuno3
1Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
JACC. Advances
|March 15, 2026
概括
2020年修订允许在日本非训练设施中进行旋转性心脏切除术 (RA),但经皮肤冠状动脉干预 (PCI) 后的住院死亡率没有增加. 这项研究没有发现培训和非培训设施在PCI结果中存在显著差异.
科学领域:
- 心血管医学 心血管医学
- 干预心脏病学 干预心脏病学
- 医疗保健服务研究 医疗服务研究
背景情况:
- 2020年4月,日本更新了在皮肤冠状动脉干预 (PCI) 期间使用旋转性心脏切除术 (RA) 的标准.
- 经过董事会认证的PCI操作员现在可以在没有手术支持 (非培训设施) 的低体积医院中进行RA.
研究的目的:
- 评估2020年RA设施标准修订对医院PCI结果的影响.
- 特别调查新获许可使用RA的非培训设施的结果.
主要方法:
- 对J-PCI注册表 (2019-2023) 的回顾性分析,涉及超过110万个PCI.
- 准实验性的差异分析,比较2020年标准修订前后的培训和非培训设施.
- 主要结局:PCI后的住院死亡率.
主要成果:
- 在PCI期间,RA使用率从4.2% (2019) 增加到5.2% (2023).
- 在培训 (1.6%至1.9%) 和非培训 (1.7%至1.9%) 设施中,住院死亡率略有上升.
- 在修订后,设施类型之间的死亡率趋势没有显著差异 (调整后P = 0.55).
结论:
- 2020年RA设施标准的修订并没有显著增加低容量,非培训设施的医院内死亡率.
- 在新认可的非培训设施和已建立的培训设施之间,PCI结果仍然可比.
相关概念视频
Peripheral Artery Disease III: Interprofessional Care
499
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
499
Coronary Artery Disease V: Interprofessional Care
363
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
363
Atherosclerosis III: Management
564
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
564


